Identification of a Disease-Defining Gene Fusion in Epithelioid HemangioendotheliomaMunir R. Tanas, Brian P. Rubin, Andrea Sboner et al.|Science Translational Medicine|2011Cited by 401
Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor SensitivityIlirjana Bajrami, Alan Ashworth, Ioannis Assiotis et al.|Cancer Research|2013Cited by 367
Large-Scale Profiling of Kinase Dependencies in Cancer Cell LinesJames Campbell, Christopher J. Lord, Colm J. Ryan et al.|Cell Reports|2016Cited by 109
Synthetic Lethal Targeting of <i>ARID1A</i> -Mutant Ovarian Clear Cell Tumors with DasatinibRowan Miller, Alan Ashworth, Rachel Brough et al.|Molecular Cancer Therapeutics|2016Cited by 85
Supplementary Methods from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast CancerBarrie Peck, Rachael Natrajan|Unknown|2023Cited by 0